Isoflavone bridging drug developed by the Radiological Research Institute of the North Korean Medical Research Institute. [사진-조선신보 갈무리]
Isoflavone capsules developed by the Radiation Medicine Research Institute of the North Korea Medical Research Institute are said to be popular due to their anti-aging and anti-radiation effects. [조선신보]reported by Pyongyang on February 29.
According to the newspaper, isoflavone is a medicinal ingredient found mainly in the flowers, leaves, fruits and roots of legumes.
Isoflavone not only has a preventive effect on cardiovascular diseases, menopausal disorder syndrome and cancerous diseases, but also has an anti-radiation effect, so it is called a plant hormone and natural antioxidant that smoothes the body’s overall metabolism.
However, because the absorption rate of isoflavones in the gastrointestinal tract is very low, even if people consume soybeans in their daily life, they are unable to absorb much of the isoflavones and excrete most of them, resulting in the absence of a clear pharmacological effect.
Isoflavone binders, recently created by researchers including director Choi Hoon of the Radiation Medicine Research Institute, are produced by removing the part that hinders the absorption and physiological activity of isoflavone extracted from the prickly pear fruit and using only the active part, so that the absorption rate is high It is said to be very high, and the treatment effect is clear.
What is especially noteworthy is that this drug not only cures diseases, but also helps protect health and maintain youth in 30-year-old adults whose skin elasticity begins to weaken.
The newspaper said: “This bridging medicine has received excellent reviews at several exhibitions, including the National Quarantine and Health Science and Technology Presentation and Exhibition-2022.”
Send Article to SNS Send Article to Facebook Send Article to Twitter Send Article to Kakao Story Send Article to Kakao Talk Copy URL Send Article to Email Send Article to Else Share Find Discarded Article
#North #Korean #Medical #Research #Institute #develops #bridging #drug #based #isoflavones.. #Delays #aging
